MicroRNA-146a: A Comprehensive Indicator of Inflammation and Oxidative Stress Status Induced in the Brain of Chronic T2DM RatsXie, Yangmei; Chu, Aiqun; Feng, Yonghao; Chen, Long; Shao, Yiye; Luo, Qiong; Deng, Xiaolin; Wu, Men; Shi, Xiaohong; Chen, Yinghui · Frontiers in Pharmacology · 2018

Linagliptin: from bench to bedsideDoupis, John · Drug Design, Development and Therapy · 2014

in miceBastaki, Salim; Abdulrazzaq, Yousef; Shafiullah, Mohamed; Więcek, Małgorzata; Kieć-Kononowicz, Katarzyna; Sadek, Bassem · Drug Design, Development and Therapy · 2018

ArrayCan, Behzat; Atilgan, Remzi; Pala, Sehmus; Kuloğlu, Tuncay; Kiray, Sule; Ilhan, Nevin · Drug Design, Development and Therapy · 2018

Neuroprotective therapies for glaucomaSong, Wei; Huang, Ping; Zhang, Chun · Drug Design, Development and Therapy · 2015

Inhaled treprostinil: a therapeutic reviewChannick, Richard; Voswinckel, ; Rubin, Lewis; Vultaggio, · Drug Design, Development and Therapy · 2012

The renoprotective effects of sulodexideVogt, Liffert; Olde Engberink, Rik · Drug Design, Development and Therapy · 2016

Antiviral therapy: a perspectiveShahidi Bonjar, Amir Hashem · Drug Design, Development and Therapy · 2016

CorrigendumMotlekar, Nelson · Drug Design, Development and Therapy · 2010